Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02574910
Recruitment Status : Recruiting
First Posted : October 14, 2015
Last Update Posted : January 25, 2019
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
University of Michigan
Children's Hospital Los Angeles
Information provided by (Responsible Party):
University of Texas Southwestern Medical Center